CYP2E1 reactions
gene
reagent
sample publication
sample review
CYP2A13
cytochrome P450 family 2 subfamily A member 13
CYP2A6
cytochrome P450 family 2 subfamily A member 6
total:1
CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody. 2006 to the paper
BD Gentest anti-human CYP2A6 monoclonal antibody was used in western blotting and immunohistochemistry to study the role of CYP2A13 in human respiratory tissues and lung cancers.
CYP2A7
cytochrome P450 family 2 subfamily A member 7
CYP2C8
cytochrome P450 family 2 subfamily C member 8
total:3
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. 2009 to the paper
BD Biosciences-Pharmingen monoclonal anti-cytochrome c antibody was used in immunohistochemistry in order to introduce a rapid regulation of mitochondrial dynamics in acute kidney injury. more
CYP2C9
cytochrome P450 family 2 subfamily C member 9
total:4
Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity. 2008 to the paper
BD Gentest anti-CYP2C9 antibody (1:1000) was used in western blot in order to study the role of cardiomyocyte CPR and CPR-dependent enzymes in doxorubicin (Dox) mediated acute cardiotoxicity more
Cyp2e1
cytochrome P450 family 2 subfamily E member 1
total:7
Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity. 2008 to the paper
Oxford Biomedical Research anti-CYP2E1 antibody (1:1000) was used in western blot in order to study the role of cardiomyocyte CPR and CPR-dependent enzymes in doxorubicin (Dox) mediated acute cardiotoxicity more
CYP2F1
cytochrome P450 family 2 subfamily F member 1
CYP2S1
cytochrome P450 family 2 subfamily S member 1